Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 3 stocks made the list for top value stocks in the Retailers - Drug industry. Those looking for value stocks to add to their portfolio may want to use this list as a starting point for further investment research.

Why Focus on Undervalued Retailers - Drug Stocks?

Value investors seek to buy stocks at a discount to their intrinsic value. Long-term returns show that such strategies are advantageous. Value stocks, as a group, tend to outperform growth stocks over extended periods of time. Typically, value investors perform financial analysis of numerous metrics, don’t follow the herd and are long-term investors.

AAII’s A+ Investor Value Grade is derived from a stock’s Value Score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

What Goes Into AAII’s Value Grade?

Stock evaluation requires access to huge amounts of data as well as the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movement. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors with that task.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for more than just value. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. Some stocks may even have null values for certain metrics like the price-earnings ratio or the price-to-book ratio but not others. An example of this would be a company with losses instead of profits or a negative book value because of heavy borrowing. Negative earnings or book value result in non-meaningful ratios that are left blank or null.

Click the button below to learn more about A+ Investor and subscribe today.

3 Undervalued Retailers - Drug Stocks

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Retailers - Drug industry for Friday, July 19, 2024. Let’s take a closer look at their individual scores to see how they measure up against each other and the Retailers - Drug industry median.

The Value Grade is assigned based on how each stock’s composite valuation compares to all other stocks.

The process for assigning grades starts with each variable for a given stock. The percentile rankings for all valid ratios that a stock has are calculated. So, for instance, a stock could have a price-to-book ranking in the 43rd percentile, a price-earnings ranking in the 67th percentile, a price-to-sales ranking in the 23rd percentile, etc. Then, those rankings are averaged for each stock. (A minimum of two valid variables are required, though all six will be used if available.)

Once the average of the individual variables is calculated, that average is ranked against all stocks. Put another way, each stock’s composite valuation is compared to all other stocks. These ranks are then sorted into quintiles from the cheapest 20% (a grade of A) to the most expensive 20% (a grade of F).

As always, we recommend that you conduct proper due diligence and research before investing in any security. We also suggest that investors utilize numerous grades, not just value, when it comes to deciding whether a company is a good fit for their allocation needs.

China Jo-Jo Drugstores Inc’s Value Grade

Value Grade:

China Jo-Jo Drugstores Inc, formerly China Jo-Jo Drugstores Holdings Inc, is a China-based retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

China Jo-Jo Drugstores Inc has a Value Score of 77, which is considered to be undervalued.

When you look at China Jo-Jo Drugstores Inc’s price-to-sales ratio at 0.02 compared to the industry median at 0.24, this company has a lower price relative to revenue compared to its peers. This could make China Jo-Jo Drugstores Inc’s stock more attractive for value investors.

Shareholder yield is the sum of a stock’s dividend yield (paid over previous 12 months minus special dividends) and the percentage of net share buybacks over the previous 12 months. China Jo-Jo Drugstores Inc’s shareholder yield is lower than its industry median ratio of (0.95%). Value investors may look for an attractive shareholder yield because it can be a powerful tool for identifying if the company has a good management team.

As one of the most common value metrics, the price-to-book ratio evaluates a company’s current market price relative to its book value. China Jo-Jo Drugstores Inc’s price-to-book ratio is lower than its industry median ratio of 0.76. This could make China Jo-Jo Drugstores Inc more attractive to investors looking for a new addition to their portfolio.

Progressive Care Inc’s Value Grade

Value Grade:

Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Progressive Care Inc has a Value Score of 80, which is considered to be undervalued.

Progressive Care Inc’s price-to-book ratio is higher than its peers. This could make Progressive Care Inc less attractive for value investors when compared to the industry median at 0.76.

You can read more about Progressive Care Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Yoshitsu Co Ltd (ADR)’s Value Grade

Value Grade:

Yoshitsu Co Ltd is a Japan-based company mainly engaged in the management of pharmacy and sale of health products, beauty products and other groceries. The Company is engaged in the supply of health products include over-the-counter (OTC) drugs, nutritional supplements, and medical supplies and devices. Its beauty products include cosmetics, skin care, fragrance, and body care. Its other products include lingerie, home goods, food, and alcoholic beverages. The Company distributes its products through physical stores, online stores, and franchise stores and wholesale customers.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Yoshitsu Co Ltd (ADR) has a Value Score of 72, which is considered to be undervalued.

Yoshitsu Co Ltd (ADR)’s price-earnings ratio is 3.5 compared to the industry median at 3.5. This means that it has a higher price relative to its earnings compared to its peers. This makes Yoshitsu Co Ltd (ADR) fairly attractive for value investors.

Yoshitsu Co Ltd (ADR)’s price-to-book ratio is higher than its peers. This could make Yoshitsu Co Ltd (ADR) less attractive for value investors when compared to the industry median at 0.76.

You can read more about Yoshitsu Co Ltd (ADR)’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Other Retailers - Drug Stock Grades

Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate revisions and quality—on the A+ Stock Grades Screener.

Also, if you want full access to all of AAII’s premium services, you can subscribe to one convenient bundled plan called AAII Platinum where you can try out A+ Investor, AAII Dividend Investing, the Stock Superstars Report, Growth Investing and VMQ Stocks. With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Retailers - Drug stocks as well as other industrys.

Choosing Which of the 3 Best Retailers - Drug Stocks Is Right for You

Choosing which value stocks to invest in will ultimately depend on your individual goals and allocation; however, comparing similar value stocks in the same industry can help you analyze which might be better investments for you in the long run. So, let’s take a look at the Value Grade for all of our stocks.

• China Jo-Jo Drugstores Inc stock has a Value Grade of B.
• Progressive Care Inc stock has a Value Grade of B.
• Yoshitsu Co Ltd (ADR) stock has a Value Grade of B.

Now that you have a bit more background about each of the 3 undervalued stocks in the Retailers - Drug industry as well as their overall grades, it’s time for you to conduct additional research to see if these could fit your portfolio needs based on your goals and risk tolerance. AAII can help you figure out both and identify which investments align with what works best for you.

We do so through a program of education that teaches you to invest for yourself and become an effective manager of your own wealth—no more relying on others for your financial independence. You can rely on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis that makes you a better investor.

A+ Investor adds to that qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

Additional Resources About Retailers - Drug Stocks

Want to learn more about Retailers - Drug stocks to see if they could be the right investment for you? Check out some additional resources and articles to help you on your financial journey.

• 3 Undervalued Retailers - Drug Stocks for Friday, July 19
• Why Walgreens Boots Alliance Inc’s (WBA) Stock Is Down 4.14%
• 3 Undervalued Retailers - Drug Stocks for Wednesday, July 17
• 3 Undervalued Retailers - Drug Stocks for Friday, July 12

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith and we accept no liability for any errors or omissions. The full disclaimer can be read here.